Adc Therapeutics Sa Stock Price on November 2, 2021
| ADCT Stock | USD 4.68 0.04 0.85% |
If you're considering investing in ADC Stock, it is important to understand the factors that can impact its price. As of today, the current price of ADC Therapeutics stands at 4.68, as last reported on the 23rd of April, with the highest price reaching 4.79 and the lowest price hitting 4.56 during the day. ADC Therapeutics is risky given 3 months investment horizon. ADC Therapeutics retains Efficiency (Sharpe Ratio) of 0.22, which signifies that the company had a 0.22% return per unit of risk over the last 3 months. We were able to break down twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.53% are justified by taking the suggested risk. Use ADC Therapeutics market risk adjusted performance of 0.4249, and Coefficient Of Variation of 411.33 to evaluate company specific risk that cannot be diversified away.
At this time, ADC Therapeutics' Common Stock Total Equity is comparatively stable compared to the past year. Stock Based Compensation is likely to gain to about 25.7 M in 2024, despite the fact that Total Stockholder Equity is likely to grow to (126.8 M). . Price To Sales Ratio is likely to drop to 1.85 in 2024. Price Earnings Ratio is likely to drop to -0.59 in 2024. ADC Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
ADC |
Sharpe Ratio = 0.2197
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ADCT | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.95 actual daily | 61 61% of assets are less volatile |
Expected Return
| 1.53 actual daily | 30 70% of assets have higher returns |
Risk-Adjusted Return
| 0.22 actual daily | 17 83% of assets perform better |
Based on monthly moving average ADC Therapeutics is performing at about 17% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ADC Therapeutics by adding it to a well-diversified portfolio.
Price Book 2.5787 | Enterprise Value Ebitda (1.43) | Price Sales 5.2087 | Shares Float 63 M | Wall Street Target Price 10.2 |
ADC Therapeutics Valuation on November 2, 2021
It is possible to determine the worth of ADC Therapeutics on a given historical date. On November 2, 2021 ADC was worth 14.54 at the beginning of the trading date compared to the closed value of 14.26. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of ADC Therapeutics stock. Still, in general, we apply an absolute valuation method to find ADC Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of ADC Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against ADC Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
04/07/2022 | 14.54 | 14.54 | 13.90 | 14.26 | 100,849 |
| 14.31 | 14.40 | 13.73 | 13.84 | 78,161 |
| Backtest ADC Therapeutics | | | ADC Therapeutics History | | | ADC Therapeutics Valuation | Next |
ADC Therapeutics Trading Date Momentum on November 2, 2021
The event impact on price volatility cannot be determined at this time. Please check this event after some time to allow current data to be analyzed.ADC Therapeutics Fundamentals Correlations and Trends
By evaluating ADC Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among ADC Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. ADC financial account trend analysis is a perfect complement when working with valuation or volatility modules.About ADC Therapeutics Stock history
ADC Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for ADC is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in ADC Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing ADC Therapeutics stock prices may prove useful in developing a viable investing in ADC Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 94 M | 75.7 M | |
| Net Loss | -140.2 M | -147.2 M |
ADC Therapeutics Quarterly Net Working Capital |
|
ADC Therapeutics Stock Technical Analysis
ADC Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
ADC Therapeutics Period Price Range
Low | April 7, 2022
| High |
14.54 | 14.26 |
ADC Therapeutics April 23, 2024 Market Strength
Market strength indicators help investors to evaluate how ADC Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ADC Therapeutics shares will generate the highest return on investment. By undertsting and applying ADC Therapeutics stock market strength indicators, traders can identify ADC Therapeutics SA entry and exit signals to maximize returns
| Accumulation Distribution | 4439.02 | |||
| Daily Balance Of Power | (0.44) | |||
| Rate Of Daily Change | 0.98 | |||
| Day Median Price | 14.22 | |||
| Day Typical Price | 14.23 | |||
| Price Action Indicator | (0.10) | |||
| Period Momentum Indicator | (9.58) |
ADC Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for ADC Therapeutics' price direction in advance. Along with the technical and fundamental analysis of ADC Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of ADC to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1588 | |||
| Jensen Alpha | 1.32 | |||
| Total Risk Alpha | 0.7654 | |||
| Sortino Ratio | 0.3374 | |||
| Treynor Ratio | 0.4149 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ADC Therapeutics SA. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the ADC Therapeutics information on this page should be used as a complementary analysis to other ADC Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for ADC Stock analysis
When running ADC Therapeutics' price analysis, check to measure ADC Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ADC Therapeutics is operating at the current time. Most of ADC Therapeutics' value examination focuses on studying past and present price action to predict the probability of ADC Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ADC Therapeutics' price. Additionally, you may evaluate how the addition of ADC Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
Is ADC Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ADC Therapeutics. If investors know ADC will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ADC Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.94) | Revenue Per Share 0.851 | Quarterly Revenue Growth (0.76) | Return On Assets (0.25) | Return On Equity (7.06) |
The market value of ADC Therapeutics is measured differently than its book value, which is the value of ADC that is recorded on the company's balance sheet. Investors also form their own opinion of ADC Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is ADC Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ADC Therapeutics' market value can be influenced by many factors that don't directly affect ADC Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ADC Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if ADC Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ADC Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.